CNR Institutional Research Information System

VISCONTI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.268
NA - Nord America 706
EU - Europa 362
SA - Sud America 215
AF - Africa 26
Totale 2.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 668
SG - Singapore 527
CN - Cina 293
BR - Brasile 178
VN - Vietnam 138
HK - Hong Kong 134
IT - Italia 126
FR - Francia 77
KR - Corea 62
DE - Germania 43
NL - Olanda 28
JP - Giappone 20
AT - Austria 17
BD - Bangladesh 16
FI - Finlandia 16
GB - Regno Unito 16
AR - Argentina 15
CA - Canada 13
IN - India 13
MX - Messico 13
ID - Indonesia 12
IL - Israele 11
IQ - Iraq 10
EC - Ecuador 8
ZA - Sudafrica 8
MA - Marocco 7
KZ - Kazakistan 5
PK - Pakistan 5
PL - Polonia 5
RU - Federazione Russa 5
CR - Costa Rica 4
KE - Kenya 4
TR - Turchia 4
UA - Ucraina 4
VE - Venezuela 4
AL - Albania 3
CO - Colombia 3
ES - Italia 3
IE - Irlanda 3
PE - Perù 3
BN - Brunei Darussalam 2
CL - Cile 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
MY - Malesia 2
SA - Arabia Saudita 2
SC - Seychelles 2
SE - Svezia 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
ZW - Zimbabwe 1
Totale 2.577
Salva come PNG Salva come JPEG
Città #
Singapore 291
Santa Clara 283
Hong Kong 133
Hefei 126
Lauterbourg 65
San Jose 63
Seoul 62
Ho Chi Minh City 52
Ashburn 46
Beijing 46
Hanoi 34
Naples 28
Los Angeles 22
São Paulo 18
New York 15
Helsinki 13
Frankfurt am Main 12
Nuremberg 12
Minamishinagawa 10
Buffalo 9
Dallas 9
Falkenstein 9
Milan 9
Rome 8
Tokyo 8
Vienna 8
Atlanta 7
Bengaluru 7
Da Nang 7
Rio de Janeiro 6
Belo Horizonte 5
Dhaka 5
Toronto 5
Bạc Liêu 4
Chicago 4
Florence 4
Haiphong 4
Hải Dương 4
Jakarta 4
Phoenix 4
Quito 4
Warsaw 4
Campinas 3
Campo Novo do Parecis 3
Johannesburg 3
Marigliano 3
Munich 3
Nairobi 3
Newark 3
Ninh Bình 3
Paternò 3
Porto Alegre 3
Portsmouth 3
Quận Năm 3
San José 3
Springfield 3
St Louis 3
Tel Aviv 3
Thái Bình 3
Tirana 3
Venice 3
Almaty 2
Amsterdam 2
Bandar Seri Begawan 2
Basra 2
Bend 2
Bến Cầu 2
Caracas 2
Cariacica 2
Casablanca 2
Caserta 2
Charlotte 2
Chesapeake 2
Cimitile 2
Cleveland 2
Contagem 2
Cordova 2
Cuiabá 2
Córdoba 2
Dublin 2
Duque de Caxias 2
Düsseldorf 2
El Cajon 2
Esmeraldas 2
Guarulhos 2
Guayaquil 2
Huế 2
Istanbul 2
Joinville 2
Juiz de Fora 2
Jundiaí 2
Kingston 2
Kyiv 2
Lima 2
Livermore 2
Madrid 2
Manaus 2
Manchester 2
Maricá 2
Memphis 2
Totale 1.604
Salva come PNG Salva come JPEG
Nome #
Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth 115
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 86
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma 74
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell Biology 74
The between now and then of lung cancer chemotherapy and immunotherapy 72
The end of mitosis from a phosphatase perspective 66
Cell cycle checkpoint in cancer: A therapeutically targetable double-edged sword 64
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer 58
Signaling by Type I and II cytokine receptors: ten years after 57
A rare adult primary intracranial sarcoma, DICER1-mutant identified by epigenomic profiling: a case report 57
Methylome profiling in Fabry disease in clinical practice: a proof of concept 55
Wee1 rather than plk1 is inhibited by AZD1775 at therapeutically relevant concentrations 54
Looking beyond the glioblastoma mask: is genomics the right path? 54
Host fecal DNA specific methylation signatures mark gut dysbiosis and inflammation in children affected by autism spectrum disorder 52
Positive effects of glucocorticoids on T cell function and development by upregulation of interleukin-7 receptor alpha 50
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs 50
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment 49
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane 49
Evaluation of MGMT gene methylation in neuroendocrine neoplasms 47
MGMT and whole-genome DNA methylation impacts on diagnosis, prognosis and therapy of glioblastoma multiforme 45
Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression 43
Ret-mediated mitogenesis requires Src kinase activity 43
Epigenetic alterations in glioblastomas: diagnostic, prognostic and therapeutic relevance 43
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment. 43
Fighting tubulin-targeting anticancer drug toxicity and resistance 42
Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines 41
Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues 39
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC. 38
Fcp-1 dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit 36
Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes 33
Characterization and analysis of the proximal Janus kinase 3 promoter 32
The suppression of thyroid cell transformation by inhibition of HMGI-C protein synthesis is associated with changes in the AP-1 activity. 32
Janus kinases and STAT family transcription factors: their role in the function and development of lymphoid cells 31
Molecular basis of severe combined immunodeficiency: lessons from cytokine signaling pathways 31
Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1 31
New insights on oxidative stress in cancer 30
Role of thrombin receptor (Par-1) molecular variant in the occurrence of coronary artery disease in hypertensive patients 30
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 30
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 29
Inhibition of Th1 immune response by glucocorticoids: Dexamethasone inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes 28
Jaks and Stats as therapeutic targets 28
Sustaining the spindle assembly checkpoint to improve cancer therapy 28
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. 28
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive 28
Overexpression of the HIP gene coding for a Heparin/Heparan Sulfate-binding protein in human thyroid carcinomas 27
RET/PTC oncogene activation is an early event in thyroid carcinogenesis 26
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression 26
Importance of the MKK6-p38 pathway for IL-12-induced Stat4 serine phosphorylation and transcriptional activity 26
Functional cloning of genes regulating apoptosis in neuronal cells 26
Glial cell line-Derived Neurotrophic Factor differentially stimulates Ret mutants associated with the Multiple Endocrine Neoplasia type 2 syndromes and Hirschsprung's disease 26
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenic mechanism of multiple endocrine neoplasia type 2B 26
The adapter molecule Gab2 is induced by lymphocyte activation and is involved in signaling by IL-2 and IL-15 but not other common gamma chain-using cytokines 25
The Platelet-derived Growth Factor Controls c-myc Expression through a JNK- and AP-1-dependent Signaling Pathway 25
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation 25
Different mutations of the RET gene cause different human tumoral diseases 25
The docking molecule Gab2 is induced by lymphocyte activation and is involved in signaling by Interleukin-2 and Interleukin-15 but not other common gamma chain-using cytokines 24
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret 24
Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways 23
Molecular biology of the MEN2 gene 23
Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity 22
The transcription factor Ets-1 is essential for janus kinase 3 (Jak3) promoter activity 22
STAT4 serine phosphorylation is critical for IL-12-induced IFN-? production but not for cell proliferation 22
Type I IFNs and regulation of Th1 responses: enigmas both resolved and emerge 21
A proximal promoter of Janus kinase 3 (Jak3) contains essential AP-1 and Ets-1 elements and is stimulated by T cell activation 21
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells 21
STAT4 serine phosphorylation is critical for IL-12 induced IFN-gamma production and Th1 differentiation 21
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor alpha 20
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients 17
Analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients 17
Totale 2.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.718
article - articoli 8.304
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 314
Totale 17.336
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 0 0 0 1 0 20 1
2024/20251.058 11 3 70 31 257 57 19 62 27 67 249 205
2025/20261.503 90 155 131 194 272 44 209 69 58 182 68 31
2026/202743 43 0 0 0 0 0 0 0 0 0 0 0
Totale 2.626